Categories Earnings, Health Care, LATEST

Gilead Sciences, Inc (GILD): Q3 2019 Earnings Snapshot

— Gilead Sciences (NYSE: GILD) reported third-quarter 2019 earnings of $1.75 per share, vs. $1.74 per share expected.

— Total revenue remained flat at $5.60 billion, vs. $5.61 billion expected. Total product sales were flat at 5.5 billion.

— Narrowed full year 2019 guidance on sales to $21.8-22.1 billion, from earlier esimtate of $21.6-22.1 billion.

— GILD shares have been trading sideways since the beginning of this year. The stock has so far declined 3% this year.

Gilead Sciences Q3 2019 earnings results.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

FAST Stock: Fastenal’s long-term prospects intact. Should you invest now?

Production disruption and logistics issues continue to have a crippling effect on the industrial sector but the performance of companies, in general, has been mixed so far. Fastenal Company (NASDAQ:

Netflix (NFLX) adds 8.3 million new subscribers in Q4: earnings beat estimates

Netflix, Inc. (NASDAQ: NFLX) Thursday said it added 8.3 million paid members in the December quarter. Revenues increased and matched estimates, aided by the relaxation of COVID restrictions and resumption

SCHW Stock: Upbeat stock market, rate hikes to drive growth for Charles Schwab

Investment management firm Charles Schwab Corporation (NYSE: SCHW) has stayed largely unaffected by the coronavirus crisis, rather it managed to tap into new opportunities. The company owes its impressive financial

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top